Pebblebrook Hotel Trust
$3.97B- Market cap
- $2.03B
- Debt
- +$2.12B
- Cash
- −$184.19M
Capital structure 49% equity / 51% debt · EV / Revenue 2.69x · EV / EBITDA 100.20x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: PEB stock price at discount vs NTLA $18.03 current versus $344.96 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NTLA's multiple
Implied fair value · at PEB's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PEB FY 2025 (ended Dec 31, 2025) · NTLA FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 49% equity / 51% debt · EV / Revenue 2.69x · EV / EBITDA 100.20x
Capital structure 93% equity / 7% debt · EV / Revenue 21.57x
PEB carries the larger enterprise value at $3.97B against $1.46B; PEB trades on the lower EV / Revenue multiple (2.69x vs 21.57x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
PEBBLEBROOK HOTEL TRUST · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
INTELLIA THERAPEUTICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.86x
0.19x
Net debt / EBITDA
Leverage against operating earnings
48.91x
0.80x
Cash and equivalents
Liquid reserves on the balance sheet
$184.19M
$449.88M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$2.12B
$124.63M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.